acquired
Stage
About
PathoQuest provides GMP-compliant next-generation sequencing (NGS) based assays for biosafety quality control and genetic characterization of biopharmaceuticals, enabling faster, safer, and animal-free testing for viral safety and biotherapy release.
Explore PathoQuest's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.